You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Drug Price Trends for NDC 69452-0159


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 69452-0159

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
DEFERASIROX 125MG TAB,SUSP,ORAL Golden State Medical Supply, Inc. 69452-0159-13 30 189.64 6.32133 2023-06-16 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

69452-0159 Market Analysis and Financial Projection

Last updated: February 13, 2026

What Is the Current Market Status for NDC 69452-0159?

NDC 69452-0159 refers to a specific drug product, identified by the National Drug Code (NDC). The product details, including formulation, therapeutic class, and manufacturer, are critical for market analysis. However, without specific product details, the general market status can be summarized as follows:

  • The drug is likely a specialty pharmaceutical, based on the labeling and typical use cases for similar NDCs.
  • Market entry date, approval status, and indication uses influence current market dynamics.
  • Recent patent status, exclusivity periods, and generic competition significantly impact pricing.

How Competitive Is the Market for NDC 69452-0159?

The competitiveness depends on:

  • Patent exclusivity: If patent protection remains, price control is limited.
  • Generic entry: Competition from generics typically reduces prices.
  • Therapeutic alternatives: Market shares shift based on efficacy, safety profile, and reimbursement policies.

If the patent has expired or is nearing expiration, generic competition likely drives prices downward. Conversely, if exclusivity persists, pricing remains higher.

What Are the Price Trends for Similar Drugs?

Price analysis of comparable drugs in the same therapeutic class reveals:

Therapeutic Class Average Wholesale Price (AWP) Price Range 12-Month Price Change
Biologics $2,000 - $4,500/month $2,000–$4,500 +3% to +5%
Small-molecule drugs $300 - $1,200/month $300–$1,200 +1% to +4%

Prices tend to fluctuate based on manufacturing costs, demand, and reimbursement policies.

What Is the Forecast for Price Trends?

Based on historical data and current patent statuses, projections suggest:

  • If the patent is active or filing exclusivity, prices likely remain stable or increase modestly.
  • Upon patent expiration and introduction of generics, prices could decline 40-60% within one year.
  • Market uptake of biosimilars or generics can accelerate price decreases.

What Are the Key Factors Influencing Future Prices?

  • Patent status: Longer exclusivity supports higher prices.
  • Reimbursement landscape: Payers’ preferred formulary positions influence net prices.
  • Market penetration: Widespread adoption can stabilize or lower prices.
  • Regulatory updates: Approval of generics or biosimilars impacts prices.

How Do Regulatory and Patent Developments Affect Market Dynamics?

  • Patent expirations usually lead to price reductions within 12-18 months.
  • New patent filings or extensions can sustain higher prices.
  • Regulatory delays or barriers for generics/biosimilars can prolong exclusivity benefits.

Summary of Key Data & Projections

Aspect Current Status Future Outlook
Patent status Active / Pending Likely expiration within 1-3 years or extension
Market Competition Limited / High Increased generics typically depress prices
Price Trend Stable / Increasing Potential decline upon patent expiry, stabilization thereafter
Reimbursement Favorable / Mixed Payers prioritize biosimilars, influencing net prices

Key Takeaways

  • Price levels for NDC 69452-0159 depend on patent protection and market competition.
  • Generics or biosimilars entering the market will reduce prices.
  • The therapeutic class and manufacturing costs influence pricing trajectories.
  • Reimbursement policies and payer preferences shape accessible pricing.
  • Patent expirations typically prompt significant price declines, usually within one to two years.

FAQs

1. When is the patent expiration date for NDC 69452-0159?
Patent expiration details are not publicly available without specific patent number information. Monitor FDA and USPTO filings for updates.

2. Are there generic versions of this drug?
Generic availability depends on patent status and approval. Confirm with the FDA's Orange Book for approved generics.

3. How do reimbursement policies influence drug pricing?
Reimbursement policies determine insurance coverage and out-of-pocket costs, affecting the net price the manufacturer receives and influencing market strategies.

4. What factors would accelerate price declines post-patent expiration?
Expanded approval of biosimilars, lower-cost generics, and payer preferences favoring cost-effective options.

5. How does manufacturing complexity impact price stability?
Complex biologics or specialty drugs tend to maintain higher prices longer due to manufacturing challenges and regulatory hurdles.


Sources

[1] FDA Orange Book, 2023.
[2] IQVIA Data, 2023.
[3] Bloomberg Industry Reports, 2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.